GO43878: A Phase III, Open-Label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients with Relapsed/Refractory Mantle Cell Lymphoma
- Title
- A Phase III, Open-Label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients with Relapsed/Refractory Mantle Cell Lymphoma
- Principal Investigator
- Safi, Salah Ud Din
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Lymphoma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Syed Abdul Mannan Shah
- Clinical Research Specialist
- Phone: +1 304-293-1683
- Email: syedabdulmannan.shah@hsc.wvu.edu